Home β€Ί Healthcare β€Ί Vaccines β€Ί Microneedles For Vaccination Market

Microneedles For Vaccination Market - Strategic Insights and Forecasts (2026-2031)

πŸ“₯ Download Free SampleπŸ’¬ Speak to Analyst
$3,950
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

3.4. Porter's Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations

3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. MICRONEEDLES FOR VACCINATION MARKET BY MATERIAL TYPE

5.1. Introduction

5.2. Silicon Microneedles

5.3. Polymer Microneedles

5.4. Metal Microneedles

5.5. Ceramic Microneedles

5.6. Dissolving Microneedles

5.7. Hollow Microneedles

6. MICRONEEDLES FOR VACCINATION MARKET BY APPLICATION

6.1. Introduction

6.2. Pediatric Vaccination

6.3. Adult Vaccination

6.4. Veterinary Vaccination

7. MICRONEEDLES FOR VACCINATION MARKET BY END-USER

7.1. Introduction

7.2. Hospitals And Clinics

7.3. Research Institutions

7.4. Pharmaceutical Companies

7.5. Vaccination Centers

8. MICRONEEDLES FOR VACCINATION MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. 3M Company

10.2. Zosano Pharma Corporation

10.3. Vaxxas Pty Ltd

10.4. Micron Biomedical, Inc.

10.5. Nanopass Technologies Ltd.

10.6. Corium International, Inc.

10.7. Theraject, Inc.

10.8. Valeritas, Inc.

10.9. Lohmann Therapie-Systeme Ag

10.10. Microdermics Inc.

11. APPENDIX

11.1. Currency

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology

11.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES

REPORT DETAILS

Report ID:KSI061615989
Published:Jan 2026
Pages:150
Format:PDF, Excel, PPT, Dashboard
πŸ“₯ Download SampleπŸ“ž Speak to AnalystπŸ“§ Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us